Inventor · disambiguated record
Marc Joseph Lajoie
Also filed as: LAJOIE MARC · LAJOIE MARC J · LAJOIE MARC JOSEPH
16 granted patents·20 pending applications·36 citations·filing 2013–2025
89Inventor score
Files withUNIV WASHINGTON16HARVARD COLLEGE8LYELL IMMUNOPHARMA INC6OUTPACE BIO INC4MASSACHUSETTS INST TECHNOLOGY2
Top patents by PatentIndex Score
36 records- 0196US11125739B2Gene editing through microfluidic deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Sep 21, 2021·13 cites·41 claims
- 0294US12130281B2Gene editing through microfluidic deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Oct 29, 2024·2 cites·23 claims
- 0391US11028383B2Polypeptide assemblies and methods for the production thereofUNIV WASHINGTON·Filed 2019·Granted Jun 8, 2021·8 cites·20 claims
- 0490US10851135B2De novo design of protein switchesUNIV WASHINGTON·Filed 2020·Granted Dec 1, 2020·3 cites·26 claims
- 0590US10501733B2Polypeptide assemblies and methods for the production thereofUNIV WASHINGTON·Filed 2016·Granted Dec 10, 2019·9 cites·25 claims
- 0679US2025304941A1Polypeptide Assemblies and Methods for the Production ThereofUNIV WASHINGTON·Filed 2025·Application pending·0 cites
- 0778US2025188125A1De novo Design of Protein SwitchesUNIV WASHINGTON·Filed 2024·Application pending·0 cites
- 0877US2023313167A1Polypeptide Assemblies and Methods for the Production ThereofUNIV WASHINGTON·Filed 2023·Application pending·0 cites
- 0972US9688994B2Methods of introducing nucleic acids into cellular DNAHARVARD COLLEGE·Filed 2013·Granted Jun 27, 2017·1 cites·18 claims
- 1070US2024409610A1Novel Recombinant Cell Surface MarkersLYELL IMMUNOPHARMA INC·Filed 2024·Application pending·0 cites
- 1168US12304927B2De novo design of protein switchesUNIV WASHINGTON·Filed 2020·Granted May 20, 2025·0 cites·10 claims
- 1267US2022246240A1Methods for Rule-based Genome DesignHARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 1366US12270032B2Codon-optimized nucleotide sequences encoding an AP-1 transcription factorLYELL IMMUNOPHARMA INC·Filed 2022·Granted Apr 8, 2025·0 cites·20 claims
- 1466US12234572B2Split interleukin mimetics and their useUNIV WASHINGTON·Filed 2019·Granted Feb 25, 2025·0 cites·16 claims
- 1563US12054531B2Recombinant cell surface markersLYELL IMMUNOPHARMA INC·Filed 2021·Granted Aug 6, 2024·0 cites·28 claims
- 1663US9834775B2Recombinant cells and organisms having persistent nonstandard amino acid dependence and methods of making themHARVARD COLLEGE·Filed 2014·Granted Dec 5, 2017·0 cites·7 claims
- 1761US12144827B2ROR1 targeting chimeric antigen receptorLYELL IMMUNOPHARMA INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 1856US11361845B2Methods for rule-based genome designHARVARD COLLEGE·Filed 2017·Granted Jun 14, 2022·0 cites·17 claims
- 1956US10570400B2Methods of introducing nucleic acids into cellular DNAHARVARD COLLEGE·Filed 2017·Granted Feb 25, 2020·0 cites·18 claims
- 2056US2025179690A1Split interleukin mimetics and their useUNIV WASHINGTON·Filed 2025·Application pending·0 cites
- 2156US2021380658A1Chimeric antigen receptor spacersLYELL IMMUNOPHARMA INC·Filed 2021·Application pending·0 cites
- 2256US2025011399A1Chimeric antigen receptorsOUTPACE BIO INC·Filed 2022·Application pending·0 cites
- 2355US2025223330A1Designed cytokine compositions and methods of useOUTPACE BIO INC·Filed 2023·Application pending·0 cites
- 2455US2025297268A1Codon-optimized nucleotide sequences encoding an ap-1 transcription factorLYELL IMMUNOPHARMA INC·Filed 2025·Application pending·0 cites
- 2553US2018187200A1Recombinant Cells and Organisms Having Persistent Nonstandard Amino Acid Dependence and Methods of Making ThemHARVARD COLLEGE·Filed 2017·Application pending·0 cites
- 2653US2023159615A1Chimeric polypeptidesOUTPACE BIO INC·Filed 2022·Application pending·0 cites
- 2751US2025268938A1Small molecule-regulated cell signaling expression systemOUTPACE BIO INC·Filed 2022·Application pending·0 cites
- 2849US2022218752A1Lockr-mediated recruitment of car t cellsUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2949US2022226485A1De novo design of phosphorylation inducible protein switches (phospho-switches)UNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 3048US2022273711A1Ultraspecific Cell Targeting Using De Novo Designed Co-Localization Dependent Protein SwitchesUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 3146US10910085B2Methods of making polypeptides with non-standard amino acids using genomically recoded organismsHARVARD COLLEGE·Filed 2015·Granted Feb 2, 2021·0 cites·11 claims
- 3244US2021380641A1Self-assembling protein structures and components thereofUNIV WASHINGTON·Filed 2018·Application pending·0 cites
- 3344US2022073565A1De novo design of protein switches for tunable control of protein degradationUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 3441US11866699B2Genome editing reagents and their useUNIV WASHINGTON·Filed 2018·Granted Jan 9, 2024·0 cites·15 claims
- 3541US2018320166A1Multiplex pairwise assembly of dna oligonucleotidesUNIV WASHINGTON·Filed 2016·Application pending·0 cites
- 3638US2021332350A1Recombinase Genome EditingHARVARD COLLEGE·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Joseph Lajoie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →